A Thorough QT/QTc Study With Laquinimod, a Novel Immunomodulator in Development for Multiple Sclerosis and Huntington Disease.
| Autor: | Spiegelstein, Ofer1 ofer.spiegelstein@tevapharm.com, Mimrod, Dorit2, Rabinovich, Laura3, Eyal, Eli4, Sprenger, Craig5, Elgart, Anna1, Samara, Emil6, Morganroth, Joel7 |
|---|---|
| Zdroj: | Clinical Pharmacology in Drug Development. Jan2019, Vol. 8 Issue 1, p49-59. 11p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|